Published in Front Plant Sci on February 28, 2017
Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer. J Clin Oncol (2009) 3.51
The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet (2003) 2.11
Plant-made vaccine antigens and biopharmaceuticals. Trends Plant Sci (2009) 1.81
Molecular farming in plants: host systems and expression technology. Trends Biotechnol (2003) 1.78
Antibody production. Adv Drug Deliv Rev (2006) 1.62
Plant-based production of biopharmaceuticals. Curr Opin Plant Biol (2004) 1.60
Approaches to achieve high-level heterologous protein production in plants. Plant Biotechnol J (2007) 1.41
Molecular cloning and sequence analysis of cDNA encoding human prostatic acid phosphatase. FEBS Lett (1988) 1.24
Recombinant protein expression for therapeutic applications. Curr Opin Biotechnol (2002) 1.22
Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A (2003) 1.16
Foreign protein degradation and instability in plants and plant tissue cultures. Trends Biotechnol (2006) 1.11
A mechanistic understanding of production instability in CHO cell lines expressing recombinant monoclonal antibodies. Biotechnol Bioeng (2011) 1.11
Expression of GA733-Fc fusion protein as a vaccine candidate for colorectal cancer in transgenic plants. J Biomed Biotechnol (2012) 0.99
Prostatic acid phosphatase expression in human tissues. Int J Clin Exp Pathol (2011) 0.97
Producing proteins in transgenic plants and animals. Curr Opin Biotechnol (2001) 0.96
Expression of recombinant vaccines and antibodies in plants. Monoclon Antib Immunodiagn Immunother (2014) 0.89
Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice. Eur J Immunol (2014) 0.88
Effect of the developmental stage and tissue position on the expression and glycosylation of recombinant glycoprotein GA733-FcK in transgenic plants. Front Plant Sci (2015) 0.87
Therapeutic vaccines for prostate cancer. Oncologist (2006) 0.86
Polymeric human Fc-fusion proteins with modified effector functions. Sci Rep (2011) 0.86
Production of antibodies in plants: approaches and perspectives. Curr Top Microbiol Immunol (2009) 0.84
Stability of transgenes in long-term micropropagation of plants of transgenic birch (Betula platyphylla). Biotechnol Lett (2010) 0.84
Mammalian cell-produced therapeutic proteins: heterogeneity derived from protein degradation. Curr Opin Biotechnol (2014) 0.82
Optimization of Ammonium Sulfate Concentration for Purification of Colorectal Cancer Vaccine Candidate Recombinant Protein GA733-FcK Isolated from Plants. Front Plant Sci (2015) 0.80
Transient Expression of Tetrameric Recombinant Human Butyrylcholinesterase in Nicotiana benthamiana. Front Plant Sci (2016) 0.78
Plant Recycling for Molecular Biofarming to Produce Recombinant Anti-Cancer mAb. Front Plant Sci (2016) 0.78